Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Irish Journal of Medical Science
|
October 27, 2019
A molecular diagnostic algorithm for JAK2 V617F investigations in suspected myeloproliferative neoplasms
Mark Alexander Catherwood, Roisin McAllister, Patrick McCallion, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 1, 2025
Concizumab prophylaxis in people with hemophilia A or B without inhibitors: patient-reported outcome results from the phase 3 explorer8 study
Pantep Angchaisuksiri, Sylvia von Mackensen, Shashikant Apte, et al.
British Journal of Haematology
|
April 25, 2026
Use of andexanet alfa: A British Society for Haematology position statement
Richard J Buka, Deepa J Arachchillage, Catherine N Bagot, et al.
Frontiers in Genetics
|
February 4, 2012
Whole genome sequences of a male and female supercentenarian, ages greater than 114 years
Paola Sebastiani, Alberto Riva, Monty Montano, et al.
Nature Medicine
|
May 2, 2002
Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy
Daniele Marras, Leslie A Bruggeman, Feng Gao, et al.
British Journal of Haematology
|
June 23, 2021
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations
Michelle Lavin, Patrick T Elder, Denis O'Keeffe, et al.
International Psychogeriatrics
|
November 20, 2019
Sleep-wake disorders in Alzheimer's disease: further genetic analyses in relation to objective sleep measures
Jerome A Yesavage, Art Noda, Alesha Heath, et al.
Blood
|
August 25, 2019
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results
Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
Blood Advances
|
March 15, 2022
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
Current Medical Research and Opinion
|
January 11, 2023
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK
Alexander T Cohen, Gary Benson, Charlotte A Bradbury, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Irish Journal of Medical Science
|
October 27, 2019
A molecular diagnostic algorithm for JAK2 V617F investigations in suspected myeloproliferative neoplasms
Mark Alexander Catherwood, Roisin McAllister, Patrick McCallion, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 1, 2025
Concizumab prophylaxis in people with hemophilia A or B without inhibitors: patient-reported outcome results from the phase 3 explorer8 study
Pantep Angchaisuksiri, Sylvia von Mackensen, Shashikant Apte, et al.
British Journal of Haematology
|
April 25, 2026
Use of andexanet alfa: A British Society for Haematology position statement
Richard J Buka, Deepa J Arachchillage, Catherine N Bagot, et al.
Frontiers in Genetics
|
February 4, 2012
Whole genome sequences of a male and female supercentenarian, ages greater than 114 years
Paola Sebastiani, Alberto Riva, Monty Montano, et al.
Nature Medicine
|
May 2, 2002
Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy
Daniele Marras, Leslie A Bruggeman, Feng Gao, et al.
British Journal of Haematology
|
June 23, 2021
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations
Michelle Lavin, Patrick T Elder, Denis O'Keeffe, et al.
International Psychogeriatrics
|
November 20, 2019
Sleep-wake disorders in Alzheimer's disease: further genetic analyses in relation to objective sleep measures
Jerome A Yesavage, Art Noda, Alesha Heath, et al.
Blood
|
August 25, 2019
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results
Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
Blood Advances
|
March 15, 2022
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
Current Medical Research and Opinion
|
January 11, 2023
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK
Alexander T Cohen, Gary Benson, Charlotte A Bradbury, et al.
Page
of 8